期刊文献+

电针对帕金森病大鼠中脑酪氨酸羟化酶mRNA表达的干预作用 被引量:2

Effect of Electroacupuncture on Expression of Tyrosine Hydroxylase Messenger RNA of PD Rats
原文传递
导出
摘要 目的:通过观察电针对PD大鼠的行为学指标的影响及其酪氨酸羟化酶mRNA表达,探讨电针对帕金森病大鼠的治疗效应和电针治疗帕金森病的可能机理。方法:通过多位点纹状体内注入6-OHDA制作PD大鼠模型。分组进行电针治疗,于治疗前、后,分别检测各组实验大鼠的旋转行为。在此基础上,采用逆转录聚合酶链反应检测各组实验大鼠中脑黑质中TH mRNA的蛋白表达,进而初步探讨电针对帕金森病治疗作用的部分机理。结果:对各组实验大鼠行为学检测显示,与模型对照组比较,电针可以有效改善帕金森病大鼠的旋转行为。通过检测各组实验大鼠中脑黑质中TH mRNA的蛋白表达情况,证实电针头穴能使帕金森病大鼠中脑酪氨酸羟化酶基因表达增加。结论:电针对帕金森病模型大鼠的旋转行为具有良好的改善效果,其机制可能是通过增加中脑TH mRNA的蛋白表达,以控制帕金森病进一步的发展。 Objective: Observing the effect of the electroacupuncture on the rotational behavior, and to discuss the partial possible mechanism by observing the expression of THmRNA in PD rats. Methods:The rat model of PD was made by injecting the 6 - hydroxy dopamine into the striatum from four points. Before and after treatment, experimental rats were measured the rotational behavior. To observe therapeutical effect of electro - acupuncture on rat model of PD according to the rotational behavior. In addtion, the expression of THmRNA was detected by RT - PCR. Results : Contrasted with the control group, expression of THmRNA was detected, which confirmed that EA could increase expression of THmRNA and improve the rotational behavior. Conclusion:EA could improve the rotational behavior of rat model of PD, and control the development of PD by increasing expression of THmRNA.
出处 《中华中医药学刊》 CAS 2009年第11期2313-2315,共3页 Chinese Archives of Traditional Chinese Medicine
基金 浙江省中医药管理局资助项目(2007CA036)
关键词 帕金森病 电针 酪氨酸羟化酶 百会 风府 Parkinson disease electroacupuncture tyrosine hydroxylase GV 20 GV 16
  • 相关文献

参考文献4

二级参考文献16

  • 1邵宴平 焦守恕 等.脑细胞悬液移植治疗黑质损伤-1.黑质损伤动物模型的建立[J].北京第二医学院学报,1986,7:107-107.
  • 2Heikkila, RE, Sonsalla PK, Duvoisin RC. Bio-chemica models of Parkinson's disease. In Neuromethods, Drugs as Tools in Neuroscience Research (Boulton AB, Baker GB, Juorio AV, Eds.), 1989, 12: 351--384.
  • 3Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rat after 6-OHDA lesions of the nigrostriatal doparnine system. Brain Res, 1970, 24:485--493.
  • 4Kirik, D, Rosenblad C, Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.Exp Neurol 1998, 152:259--277.
  • 5Deumens R, Blokland A, Priekaerts J. Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway. Exp Neurol, 2002,175 (2): 303--317.
  • 6Kirik D, Rosenblad C, Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol, 1998, 152 (2): 259--277.
  • 7Winkler C, Kirik D, Bjorklund A, et al. L-DOPA-indueed dyskinesia in the intrastriatal 6-hydroxydoparnine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis, 2002 Jul; 10 (2): 165--186.
  • 8Lee CS, Sauer H, Bjorklund A. Opaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience, 1996, 72 (3): 641--653.
  • 9Hudson, J L, Van Home CG, Stromberg I, et al. Correlation of apomorphine-and amphetamine-induced turningwith nigrostriatal dopamine eontent in unilateral 6-hy-droxydoparnine lesioned rats. Brain Res, 1993,626:167--174.
  • 10Ryoo HL, Pierrotti D, Joyce J N. Dopaimine D3 receptor is decresed and D2 receptor is elevated in striaturn of Parkinson's disease. MOV Discord, 1998, 13:788--797.

共引文献30

同被引文献37

  • 1韩振,王化珍.帕金森病的致病基因及基因治疗[J].基层医学论坛,2005,9(6):553-554. 被引量:1
  • 2张晓录 ,张逢春 ,李尧华 .酪氨酸羟化酶与帕金森病的关系研究[J].北华大学学报(自然科学版),2005,6(3):224-227. 被引量:12
  • 3陈彪,刘焯霖,梁秀龄,潘锡榜.帕金森氏病的遗传流行病学——88例病例对照研究[J].遗传与疾病,1989,6(2):87-89. 被引量:2
  • 4彭继英,孙异临.与帕金森病相关的致病基因研究进展[J].首都医科大学学报,2006,27(2):271-274. 被引量:4
  • 5Plato CC, Cruz MT, Kurland LT. Amyotrophic lateral sclerosis- Parkinsonism dementia complex of Guam: further genetic investiga- tions[J]. Am J Hum Genet, 1969, 21 (2) : 133-141.
  • 6Braak H, Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson' s disease [ J ]. Adv Anat Embryol Cell Biol,2009,201 ( 1 ) : 1-119.
  • 7Hasegawa T, Treis A, Patenge N, et al. Parkin protects a- gainst tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways [ J ]. J Neuroehem,2008,105 (5) : 1700-1715.
  • 8Xi Y, Ryan J, Noble S, et al. Impaired dopaminergic neu- ron development and locomotor function in zebrafish with loss of PINK1 function [ J ]. Eur J Neurosci, 2010, 31 (4) :623-633.
  • 9Jiang C, Wan X, Jankovic J, et al. Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson' s disease [ J ]. Clinical Neuro- pharmacology ,2004,27 ( 2 ) :63-73.
  • 10Henn IH, Bouman L, Schlehe JS, et al. Parkin mendiates neuroprotection through activation of Ikappa B kinase/nu- clear factor-kappa B signaling [ J ]. J Neurosci, 2007,27 (8) : 1868-1878.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部